Your browser doesn't support javascript.
loading
Pembrolizumab-induced vitiligo in a patient with lung adenocarcinoma: A case report.
Bulat, Vedrana; Likic, Robert; Bradic, Lada; Speeckaert, Reinhart; Azdajic, Marija Delas.
Afiliação
  • Bulat V; Department of Dermatology and Venereology, University Hospital Centre Sestre Milosrdnice, Vinogradska cesta, Zagreb, 29, Croatia.
  • Likic R; University of Zagreb School of Medicine, Zagreb, Croatia.
  • Bradic L; Associate Professor, Division for Clinical Pharmacology and Therapeutics, Department of Internal Medicine University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, Croatia.
  • Speeckaert R; Department of Cardiology, University Hospital Centre Zagreb, Kispaticeva 12, Zagreb, Croatia.
  • Azdajic MD; Department of Dermatology, Ghent University Hospital; De Pintelaan 185, Ghent, Belgium.
Br J Clin Pharmacol ; 87(6): 2614-2618, 2021 06.
Article em En | MEDLINE | ID: mdl-33217043
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vitiligo / Antineoplásicos Imunológicos / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Vitiligo / Antineoplásicos Imunológicos / Adenocarcinoma de Pulmão / Neoplasias Pulmonares Limite: Female / Humans / Middle aged Idioma: En Ano de publicação: 2021 Tipo de documento: Article